TWST:NASDAQ
Twist Bioscience Corp
$69.22
arrow_downward
-6.37%(-4.71) 1D
$70.00
arrow_upward
+1.13% (+0.78)bedtimeAfter hours
Closed: Jun 5, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
$72.34
High
$73.70
Low
$68.29
Mkt. cap
4.31B
Avg. vol.
1.53M
Volume
2.47M
52-wk high
$80.50
52-wk low
$23.30
EPS
-$1.33
Beta
2.23
Shares outstanding
62.27M
No. of employees
979
Open
$72.34
High
$73.70
Low
$68.29
Mkt. cap
4.31B
Avg. vol.
1.53M
Volume
2.47M
52-wk high
$80.50
52-wk low
$23.30
EPS
-$1.33
Beta
2.23
Shares outstanding
62.27M
No. of employees
979
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to TWST in the past 3 months
Strong Buy
Buy
7
Hold
0
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for TWST in the last 3 months.
Highest
Current $69.22
$70.00 (+1.13%)
Average
$64.00 (-7.54%)
Lowest
$56.00 (-19.10%)
News stories
From sources across the web
The Motley Fool
·
6 hours ago
Twist Bioscience's Chief Legal Officer Sold Over 14,000 Company Shares. What Does That Mean for Investors?
Yahoo Finance
·
2 days ago
How The Investment Story For Twist Bioscience (TWST) Is Evolving With Recent Developments
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp
AI content may include mistakes. Learn more